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 Development of a CBPR Protocol for an IDU Focus Group on  
Overdose Prevention and Naloxone Training & Distribution   
 
Julie Gleason-Comstock, PhD, CHES 
Wayne State University (WSU) Department of Family Medicine &  
Public Health Sciences and Center for Urban Studies (CUS), Office of the Provost 
 
Opioid overdose is a leading cause of death among injection drug users (IDU).  Naloxone is an 
effective opiate antagonist used by medical personnel for emergency resuscitation. To provide 
guidance for an urban public health initiative on naloxone training and distribution,  a 
community health organization which operates a syringe exchange program, a local health 
department and a research university used an existing Community-Based Participatory Research  
(CBPR) relationship to develop a focus group protocol to receive input from IDU.  
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METHODS
COMMUNITY-BASED PARTICIPATORY RESEARCH  WITH AN INTRAVENOUS DRUG USERS FOCUS GROUP  ON OVERDOSE REVERSAL
Julie Gleason-Comstock, PhD, CHES, Alicia Streater, PhD,  Mark Sorbo, BA, Wayne State University (WSU)
Cindy Bolden Calhoun, Barbara Jones, Craig Miller, Community Health Awareness Group, Inc.  (CHAG)
Luke  Bergmann, PhD, City of Detroit Department of Health & Wellness Promotion (DHWP)
BACKGROUND
INTRODUCTION
A  Community-Based Participatory Research  collaborative 
between the  City of Detroit Department of Health and Wellness 
Promotion , Community Health Awareness Group , Inc. and 
researchers from the WSU Center for Urban Studies , Office of the 
Provost, and  the Department of  Family Medicine & Public Health 
Sciences , School of Medicine, explored the feasibility of adapting the  
Chicago Recovery Alliance model for prevention of opiate overdose 
related death in the City of Detroit. 
The opiate reversal program is planned as a natural expansion 
of services provided through CHAG’s Life Points Harm Reduction 
Outreach program. Life Points has provided syringe exchange, 
HIV/AIDS and Hepatitis C risk reduction education,  referrals to drug 
treatment and HIV/AIDS testing to injecting drug users and others 
through mobile street outreach since 1996. The naloxone distribution 
program will be implemented through Life Points in  late 2009.
RESULTS
INJECTING ENVIRONMENTS
• 80% of the respondents said they inject primarily in private locations
• Usually with friends and in their own homes
• 44% usually inject with a regular injecting partner
• Only 25% ever injected in a shooting gallery. 
• 31%  always inject alone 
• Most like privacy when using; don’t like others watching while inject
• Many expressed feeling safe when they get high by themselves because 
they can’t afford enough dope to put them over the top or they always 
buy from someone they know.
OVERDOSE EXPERIENCES IN THE LAST 12 MONTHS
• 75% knew someone who overdosed at least once
• 19% had overdosed themselves
• Most often the OD occurred in their own house
USUAL RESPONSES TO OVERDOSE
• Actions taken
• Shake or slap them around
• Walk them around
• Place ice water on genitals; keep temperature down
• Rescue Breathing
• Reasons for inaction: fear of arrest 
• “People end up dying (from overdose) because people are afraid they 
will be charged with murder or maybe they have warrants so they 
don’t want to take them to the hospital.”
• “They should have amnesty like you have for babies for people who 
OD. You could be charged for murder. Ease up on people when they 
drop off someone who OD’d”
WILLINGNESS TO USE NALOXONE AND INFORM OTHERS
• 100% were willing to carry and use naloxone when witnessing an OD
• “Even if I was high...  it would wake me up, blow my high so I would be 
able to deal with it.”
• “You can work it out with someone where you say” I’ve got this and you 
give that so that if one of us falls out, you can hit me… ”
• “Hey we still have a heart and conscience, even if we don’t know each 
other, we would do it.”
PARTICIPANT CHARACTERISTICS
• 56%  Female
• Race/Ethnicity
• 44% African-American
• 38% White, non Hispanic
• 12%  White, Hispanic 
• 6% American Indian
• Age 
• 25- 30 (12%)
• 31- 39 (12%)
• 40 – 49 (38%)
• 50 + (38%)
• Education
• 8th grade or less (13%)
• Some high school (25%)
• High school graduate/GED (38%)
• College (25%)
Opiod overdose is a leading cause of death among injection drug 
users (IDU).  Naloxone is an effective opiate antagonist used by medical 
personnel for over thirty years for emergency resuscitation.  Except for 
potential dope sickness, the drug has no side effects and no  
pharmacological effect when opiates are absent. 
Recently community-based harm reduction programs have 
developed a training and distribution program in which injecting drug 
users themselves can administer naloxone in case of opiate overdose. 
Although it does not completely eliminate the need for medical 
intervention, the program can prevent unnecessary death from opiate 
overdose by allowing trained bystanders to inject naloxone immediately 
instead of  using multiple ineffective methods to revive someone before 
calling 911.    Studies show that injecting drug users are willing to and 
do use the naloxone to prevent overdose death and that it does not 
increase the frequency or quantity of opiates used .
Presentation:  Michigan’s  Premier Public Health Conference, 2009  
. In preparation to implement this program, sixteen intravenous drug 
users (IDU), all registered members of the Life Points program, participated 
in one of two focus groups. Questions explored the IDU  typical injecting 
environment, experiences with drug overdose and their opinions about using 
naloxone in the community. Prior to the group, all participants completed a 
brief survey and watched a 10 minute video about naloxone.
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